Literature DB >> 2705359

Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging.

G Koelbel1, U Schmiedl, M C Majer, P Weber, H Jenss, K Kueper, C F Hess.   

Abstract

To investigate the potential of MR imaging in the evaluation of sinus tracts or fistulae associated with Crohn disease, 17 patients with pelvic or abdominal fistulae or sinus tracts underwent MR imaging with multislice spin-echo techniques, 500/15 and 1600/22,80 (TR/TE). The presence of fistulae and/or sinus tracts was confirmed by contrast-enhanced CT (n = 17) and/or sonography (n = 8), sinography (n = 6), or barium studies (n = 4). In all but three cases the fistulae and extramucosal inflammatory abnormalities were shown by MR. T1-weighted images provided excellent delineation of the extension of the fistulae relative to sphincters and adjacent hollow viscera and showed inflammatory changes in fat planes. T2-weighted images showed fluid collections within the fistulae, localized fluid collections in extraintestinal tissues, and inflammatory changes within muscles. The supralevator and infralevator compartments were well defined on coronal images. Thus, the perirectal spread of fistulae and sinus tracts with respect to the levator ani could be demonstrated in all cases. Our results suggest that MR imaging is useful for the demonstration and evaluation of pelvic and abdominal sinus tracts or fistulae associated with Crohn disease.

Entities:  

Mesh:

Year:  1989        PMID: 2705359     DOI: 10.2214/ajr.152.5.999

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  26 in total

Review 1.  MRI in patients with inflammatory bowel disease.

Authors:  Michael S Gee; Mukesh G Harisinghani
Journal:  J Magn Reson Imaging       Date:  2011-03       Impact factor: 4.813

Review 2.  New diagnostic imaging tools for inflammatory bowel disease.

Authors:  B A Mackalski; C N Bernstein
Journal:  Gut       Date:  2006-05       Impact factor: 23.059

Review 3.  CT and MRI of paediatric Crohn disease.

Authors:  Paolo Toma; Claudio Granata; Gianmichele Magnano; Arrigo Barabino
Journal:  Pediatr Radiol       Date:  2007-09-25

4.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

5.  Endoscopic ultrasound to guide the combined medical and surgical management of pediatric perianal Crohn's disease.

Authors:  Michael J Rosen; Dedrick E Moulton; Tatsuki Koyama; Walter M Morgan; Stephen E Morrow; Alan J Herline; Roberta L Muldoon; Paul E Wise; D Brent Polk; David A Schwartz
Journal:  Inflamm Bowel Dis       Date:  2010-03       Impact factor: 5.325

Review 6.  [Progress in diagnostics of anorectal disorders. Part II: radiology].

Authors:  F G Bader; R Bouchard; A Lubienski; R Keller; L Mirow; R Czymek; J K Habermann; H-P Bruch; U J Roblick
Journal:  Chirurg       Date:  2008-05       Impact factor: 0.955

7.  Radiographic and endoscopic diagnosis and treatment of enterocutaneous fistulas.

Authors:  Jennifer K Lee; Sharon L Stein
Journal:  Clin Colon Rectal Surg       Date:  2010-09

8.  Magnetic resonance imaging (MRI) evaluation of perianal fistulae with surgical correlation.

Authors:  Kulvinder Singh; Navdeep Singh; Cl Thukral; Kunwar Pal Singh; Varun Bhalla
Journal:  J Clin Diagn Res       Date:  2014-06-20

9.  High-output fistula.

Authors:  Naila Arebi; Alastair Forbes
Journal:  Clin Colon Rectal Surg       Date:  2004-05

10.  Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging.

Authors:  P J Haggett; N R Moore; J D Shearman; S P Travis; D P Jewell; N J Mortensen
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.